Stock Markets April 21, 2026 06:59 AM

Barclays, Lloyds and UBS Added to FCA AI Lab for Live Testing of Banking Applications

UK regulator expands controlled pilot to evaluate real-world AI use across banks and fintechs

By Leila Farooq NWG
Barclays, Lloyds and UBS Added to FCA AI Lab for Live Testing of Banking Applications
NWG

The Financial Conduct Authority has approved a new cohort of banks and fintech firms, including Barclays, Lloyds and UBS, to develop and trial artificial intelligence applications in a controlled live-market environment. The program will investigate a range of AI approaches, from agentic systems to neurosymbolic techniques that combine machine learning and structured reasoning, with tests scheduled to finish by year-end.

Key Points

  • The FCA has authorized Barclays, Lloyds and UBS to develop and test AI applications through its AI Lab program, which aims to assess risks and develop secure tools for consumers and markets.
  • Testing will cover a range of AI approaches, including agentic AI and neurosymbolic AI that combines machine learning with structured reasoning; trials will take place in a controlled live-market environment and are due to finish by year-end.
  • Other participants in the latest cohort include Experian (EXPN), Aereve, Coadjute, GoCardless and Palindrome; an earlier cohort including NatWest (NWG), Monzo and Scottish Widows previously tested applications for about six months.

The Financial Conduct Authority said on Tuesday that Barclays Plc, Lloyds Banking Group Plc and UBS Group AG are among the newest participants authorized to create and test artificial intelligence applications under its AI Lab initiative.

The FCA described the Lab as a framework to examine risks and help produce tools intended to protect consumers and support market integrity while formal regulatory rules remain undeveloped. Firms in the program will assess multiple model types - including agentic AI and neurosymbolic AI, the latter of which blends machine learning with structured reasoning, according to the regulator.

"We’re continuing to collaborate with firms to support the safe and responsible development of AI in UK financial markets," Jessica Rusu, the FCA’s chief data, information and intelligence officer, said in a statement.

According to the FCA, Lloyds has engaged with the regulator on its approach to safe AI deployment, including exploring potential uses such as financial guidance. Britain’s largest mortgage lender reportedly deployed thousands of employees to test an AI-powered financial assistant aimed at helping customers manage spending, saving and investments.

In addition to Barclays, Lloyds and UBS, the latest group approved for testing includes Experian Plc (LON:EXPN), Aereve, Coadjute, GoCardless and Palindrome. The regulator said the trials will run within a controlled live-market setting that may involve real customers, with the testing phase expected to conclude by the end of this year.

The FCA noted that an earlier cohort - which included NatWest Group Plc (LON:NWG), fintech Monzo Bank and Lloyds’ pension arm Scottish Widows - had carried out tests for about six months.


The program is positioned as an interim measure to identify and mitigate risks from real-world AI use in financial services, and to inform future regulatory decisions. The FCA’s description emphasizes practical assessment in the absence of codified rules, rather than setting new regulatory obligations at this stage.

Risks

  • Unclear regulatory framework - The program operates while formal, codified rules for AI in financial services are not yet established, creating uncertainty for firms and markets.
  • Live-market exposure - Trials involve real customers in a controlled live setting, which introduces the risk of consumer impact if issues arise during testing.

More from Stock Markets

Paramount refashions mobile app to ride short-video wave Apr 21, 2026 Analyst Sees 2026 Weakness in Reddit Stock as a Buying Opportunity Apr 21, 2026 Webull Board Approves $100 Million Share Repurchase; Stock Jumps 5.5% Apr 21, 2026 U.S. Futures Rise Ahead of Warsh Hearing as Amazon, UnitedHealth Gain and 3M Falls Apr 21, 2026 Barclays Identifies Seven Consumer Staples to Lean on as Macro Risks Persist Apr 21, 2026